1. Home
  2. JFU vs NEPH Comparison

JFU vs NEPH Comparison

Compare JFU & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 9F Inc.

JFU

9F Inc.

HOLD

Current Price

$3.08

Market Cap

46.7M

Sector

Finance

ML Signal

HOLD

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$3.65

Market Cap

37.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JFU
NEPH
Founded
2006
1997
Country
China
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
46.7M
37.7M
IPO Year
2018
2004

Fundamental Metrics

Financial Performance
Metric
JFU
NEPH
Price
$3.08
$3.65
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
7.2K
32.6K
Earning Date
12-09-2022
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1000.00
EPS
N/A
0.01
Revenue
N/A
$18,789,000.00
Revenue This Year
N/A
$11.24
Revenue Next Year
N/A
$11.58
P/E Ratio
$1.43
$369.50
Revenue Growth
N/A
32.67
52 Week Low
$1.25
$2.66
52 Week High
$9.48
$6.42

Technical Indicators

Market Signals
Indicator
JFU
NEPH
Relative Strength Index (RSI) 41.97 57.72
Support Level $2.65 $3.64
Resistance Level $4.79 $3.78
Average True Range (ATR) 0.47 0.28
MACD -0.07 0.03
Stochastic Oscillator 7.07 85.23

Price Performance

Historical Comparison
JFU
NEPH

About JFU 9F Inc.

9F Inc is a digital technology and wealth management service provider aiming to empower institutional partners with financial technologies as well as attract investors with investment opportunities that come with the vast potential of China's new consumer economy and the appreciation of world-wide assets and access to quality products at a competitive price. The Company's operations are organized into segments, consisting of E-commerce services, technology Empowerment service, and Wealth Management services.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: